Product correctly added to cart.

discount label
H-RLVDDFLL^V-OH
View 3D

Biosynth logo

H-RLVDDFLL^V-OH

Ref. 3D-PP47564

Undefined sizeTo inquire
Estimated delivery in United States, on Tuesday 10 Dec 2024

Product Information

Name:
H-RLVDDFLL^V-OH
Description:

Peptide H-RLVDDFLL^V-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RLVDDFLL^V-OH include the following: Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region L Wooldridge , A Lissina, J Vernazza - European journal of , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200636765 Artificial Antigen-Presenting Cells Transduced with Telomerase Efficiently Expand Epitope-Specific, Human Leukocyte Antigen-Restricted Cytotoxic T Cells J Dupont, JB Latouche, C Ma, M Sadelain - Cancer research, 2005 - AACRhttps://aacrjournals.org/cancerres/article-abstract/65/12/5417/518137 Vaccines as consolidation therapy for myeloid leukemia G Alatrash , JJ Molldrem - Expert review of hematology, 2011 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1586/ehm.10.80 Tumor-associated antigens G Alatrash , AK Crain, JJ Molldrem - Immune biology of allogeneic , 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780128126301000074 Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs). C Ragone, C Manolio, B Cavalluzzo - for ImmunoTherapy of , 2021 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166618/ Telomerase based anticancer immunotherapy and vaccines approaches C Kailashiya, HB Sharma , J Kailashiya - Vaccine, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X17312276 Cytotoxic T cell immunity against telomerase reverse transcriptase in humans B Minev, J Hipp, H Firat, JD Schmidt - Proceedings of the , 2000 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.070560797 Recent patents on anti-telomerase cancer therapy A Agrawal , S Dang , R Gabrani - Recent patents on anti-cancer , 2012 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/pra/2012/00000007/00000001/art00008

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-PP47564 H-RLVDDFLL^V-OH

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".